Olanzapine‐Based Triple Regimens Versus Neurokinin‐1 Receptor Antagonist‐Based Triple Regimens in Preventing Chemotherapy‐Induced Nausea and Vomiting Associated with Highly Emetogenic Chemotherapy: A Network Meta‐Analysis

BACKGROUND. The current antiemetic prophylaxis for patients treated with highly emetogenic chemotherapy (HEC) included the olanzapine‐based triplet and neurokinin‐1 receptor antagonists (NK‐1RAs)‐based triplet. However, which one shows better antiemetic effect remained unclear. MATERIALS AND METHODS...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Zhang, Zhonghan, Zhang, Yaxiong, Chen, Gang, Hong, Shaodong, Yang, Yunpeng, Fang, Wenfeng, Luo, Fan, Chen, Xi, Ma, Yuxiang, Zhao, Yuanyuan, Zhan, Jianhua, Xue, Cong, Hou, Xue, Zhou, Ting, Ma, Shuxiang, Gao, Fangfang, Huang, Yan, Chen, Likun, Zhou, Ningning, Zhao, Hongyun, Zhang, Li
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2018
Assuntos:
Symptom Management and Supportive Care
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5947448/
https://ncbi.nlm.nih.gov/pubmed/29330211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0378
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados